glp-1 data Use Has More Than Quadrupled Since 2021 as Obesity Rates Continue to Show Signs of Decline Monitoring Report: GLP-1 RA Prescribing

These combined effects result in several clinically meaningful outcomes: Improved blood sugar control For people with type 2 diabetes, GLP-1s help reduce both fasting and post-meal blood glucose, often allowing for a reduction in other medications

More than 42% of adults under 65 with private insurance could be eligible for these medications under current FDA guidelines

Depending on the substance and test type, there are different ways to check for possible use

Homocysteine reduction from a baseline above 10 mol/L is associated with reduced cardiovascular risk and slowed epigenetic aging rate

Dehydrocostuslactone, a medicinal plant-derived sesquiterpene lactone, induces apoptosis coupled to endoplasmic reticulum stress in liver cancer cells

Despite the elevated heart rate, cardiovascular outcome trials have shown net cardiovascular benefits, suggesting that the modest chronotropic effect is outweighed by other protective mechanisms